FUSED HETEROCYCLIC RINGS AS RIPK1 INHIBITORS
The invention provides novel substituted heterocyclic rings represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of RIPK1 and the therape...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PARK, Kitae KIM, Minha SEO, Jeongbeob HAN, Cheolkyu CHOI, Sungmin KIM, Jinyoung JEON, Seeun KWON, Youngeun KANG, Hongjun JEONG, Heejin YOON, Cheolhwan KIM, Sunjoo KIM, Namhee HAN, Sangbae MIN, Jiae YANG, Inho |
| description | The invention provides novel substituted heterocyclic rings represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of RIPK1 and the therapeutic methods. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2022346718A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2022346718A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2022346718A13</originalsourceid><addsrcrecordid>eNrjZNBxCw12dVHwcA1xDfJ3jnT28XRWCPL0cw9WcAwGMgK8DRU8_Tw8nTxD_IOCeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvGOokYGRkbGJmbmhhaOhMXGqACSxJfc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FUSED HETEROCYCLIC RINGS AS RIPK1 INHIBITORS</title><source>esp@cenet</source><creator>PARK, Kitae ; KIM, Minha ; SEO, Jeongbeob ; HAN, Cheolkyu ; CHOI, Sungmin ; KIM, Jinyoung ; JEON, Seeun ; KWON, Youngeun ; KANG, Hongjun ; JEONG, Heejin ; YOON, Cheolhwan ; KIM, Sunjoo ; KIM, Namhee ; HAN, Sangbae ; MIN, Jiae ; YANG, Inho</creator><creatorcontrib>PARK, Kitae ; KIM, Minha ; SEO, Jeongbeob ; HAN, Cheolkyu ; CHOI, Sungmin ; KIM, Jinyoung ; JEON, Seeun ; KWON, Youngeun ; KANG, Hongjun ; JEONG, Heejin ; YOON, Cheolhwan ; KIM, Sunjoo ; KIM, Namhee ; HAN, Sangbae ; MIN, Jiae ; YANG, Inho</creatorcontrib><description>The invention provides novel substituted heterocyclic rings represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of RIPK1 and the therapeutic methods.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240328&DB=EPODOC&CC=AU&NR=2022346718A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240328&DB=EPODOC&CC=AU&NR=2022346718A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PARK, Kitae</creatorcontrib><creatorcontrib>KIM, Minha</creatorcontrib><creatorcontrib>SEO, Jeongbeob</creatorcontrib><creatorcontrib>HAN, Cheolkyu</creatorcontrib><creatorcontrib>CHOI, Sungmin</creatorcontrib><creatorcontrib>KIM, Jinyoung</creatorcontrib><creatorcontrib>JEON, Seeun</creatorcontrib><creatorcontrib>KWON, Youngeun</creatorcontrib><creatorcontrib>KANG, Hongjun</creatorcontrib><creatorcontrib>JEONG, Heejin</creatorcontrib><creatorcontrib>YOON, Cheolhwan</creatorcontrib><creatorcontrib>KIM, Sunjoo</creatorcontrib><creatorcontrib>KIM, Namhee</creatorcontrib><creatorcontrib>HAN, Sangbae</creatorcontrib><creatorcontrib>MIN, Jiae</creatorcontrib><creatorcontrib>YANG, Inho</creatorcontrib><title>FUSED HETEROCYCLIC RINGS AS RIPK1 INHIBITORS</title><description>The invention provides novel substituted heterocyclic rings represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of RIPK1 and the therapeutic methods.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBxCw12dVHwcA1xDfJ3jnT28XRWCPL0cw9WcAwGMgK8DRU8_Tw8nTxD_IOCeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvGOokYGRkbGJmbmhhaOhMXGqACSxJfc</recordid><startdate>20240328</startdate><enddate>20240328</enddate><creator>PARK, Kitae</creator><creator>KIM, Minha</creator><creator>SEO, Jeongbeob</creator><creator>HAN, Cheolkyu</creator><creator>CHOI, Sungmin</creator><creator>KIM, Jinyoung</creator><creator>JEON, Seeun</creator><creator>KWON, Youngeun</creator><creator>KANG, Hongjun</creator><creator>JEONG, Heejin</creator><creator>YOON, Cheolhwan</creator><creator>KIM, Sunjoo</creator><creator>KIM, Namhee</creator><creator>HAN, Sangbae</creator><creator>MIN, Jiae</creator><creator>YANG, Inho</creator><scope>EVB</scope></search><sort><creationdate>20240328</creationdate><title>FUSED HETEROCYCLIC RINGS AS RIPK1 INHIBITORS</title><author>PARK, Kitae ; KIM, Minha ; SEO, Jeongbeob ; HAN, Cheolkyu ; CHOI, Sungmin ; KIM, Jinyoung ; JEON, Seeun ; KWON, Youngeun ; KANG, Hongjun ; JEONG, Heejin ; YOON, Cheolhwan ; KIM, Sunjoo ; KIM, Namhee ; HAN, Sangbae ; MIN, Jiae ; YANG, Inho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2022346718A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PARK, Kitae</creatorcontrib><creatorcontrib>KIM, Minha</creatorcontrib><creatorcontrib>SEO, Jeongbeob</creatorcontrib><creatorcontrib>HAN, Cheolkyu</creatorcontrib><creatorcontrib>CHOI, Sungmin</creatorcontrib><creatorcontrib>KIM, Jinyoung</creatorcontrib><creatorcontrib>JEON, Seeun</creatorcontrib><creatorcontrib>KWON, Youngeun</creatorcontrib><creatorcontrib>KANG, Hongjun</creatorcontrib><creatorcontrib>JEONG, Heejin</creatorcontrib><creatorcontrib>YOON, Cheolhwan</creatorcontrib><creatorcontrib>KIM, Sunjoo</creatorcontrib><creatorcontrib>KIM, Namhee</creatorcontrib><creatorcontrib>HAN, Sangbae</creatorcontrib><creatorcontrib>MIN, Jiae</creatorcontrib><creatorcontrib>YANG, Inho</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PARK, Kitae</au><au>KIM, Minha</au><au>SEO, Jeongbeob</au><au>HAN, Cheolkyu</au><au>CHOI, Sungmin</au><au>KIM, Jinyoung</au><au>JEON, Seeun</au><au>KWON, Youngeun</au><au>KANG, Hongjun</au><au>JEONG, Heejin</au><au>YOON, Cheolhwan</au><au>KIM, Sunjoo</au><au>KIM, Namhee</au><au>HAN, Sangbae</au><au>MIN, Jiae</au><au>YANG, Inho</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FUSED HETEROCYCLIC RINGS AS RIPK1 INHIBITORS</title><date>2024-03-28</date><risdate>2024</risdate><abstract>The invention provides novel substituted heterocyclic rings represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of RIPK1 and the therapeutic methods.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2022346718A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | FUSED HETEROCYCLIC RINGS AS RIPK1 INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T05%3A11%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PARK,%20Kitae&rft.date=2024-03-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2022346718A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |